Peak flow meter having a questionnaire and small-spirometer to assist identify bronchial asthma and Chronic obstructive pulmonary disease in tangible-existence clinical practice: a mix-sectional study

  • 1.

    Gonzalez-Garcia, M., Caballero, A., Jaramillo, C., Maldonado, D. & Torres-Duque, C. A. Prevalence, risks and underdiagnosis of bronchial asthma and wheezing in grown-ups 4 decades and older: a population-based study. J. Bronchial asthma , 1–8 (2015).

  • 2.

    Pakhale, S., Sumner, A., Coyle, D., Vandemheen, K. & Aaron, S. (Correcting) misdiagnoses of bronchial asthma: an expense effectiveness analysis. BMC Pulm. Mediterranean. 11, 27 (2011).

  • 3.

    Aaron, S. D., Vandemheen, K. L., Boulet, L. P., McIvor, R. A., FitzGerald, J. M. & Hernandez, P. et al. Overdiagnosis of bronchial asthma in obese and nonobese adults. Can. Mediterranean. Ass. J. 179, 1121–1131 (2008).

  • 4.

    Lamprecht, B., Soriano, J. B., Studnicka, M., Kaiser, B., Vanfleteren, L. E. & Gnatiuc, L. et al. Determinants of underdiagnosis of Chronic obstructive pulmonary disease in national and worldwide surveys. Chest J. 148, 971–985 (2015).

  • 5.

    Vanjare, N., Chhowala, S., Madas, S., Kodgule, R., Gogtay, J. & Salvi, S. Utilization of spirometry among chest physicians and doctors in India. NPJ Prim. Care Respir. Mediterranean. 2636, 1–4 (2016).

  • 6.

    Hansen, T. E., Evjenth, B. & Holt, J. Validation of the questionnaire against clinical assessment in detecting bronchial asthma in class children. J. Bronchial asthma 52, 262–267 (2015).

  • 7.

    Coordination Committee for that Worldwide Study of Bronchial asthma and Allergic reactions in early childhood (ISAAC). (1992). Manual for that Worldwide Study for Bronchial asthma and Allergic reactions in early childhood (ISAAC). http://isaac.auckland.ac.nz/phases/phaseone/phaseonemanual.pdf

  • 8.

    Stanley, A. J., Hasan, I., Crockett, A. J., van Schayck, O. C. P. & Zwar, N. A. Chronic obstructive pulmonary disease Diagnostic Questionnaire (CDQ) for choosing at-risk patients for spirometry: a mix-sectional study in Australian general practice. NPJ Prim. Care Respir. Mediterranean. 24, 14024 (2014).

  • 9.

    Cost, D. B., Tinkelman, D. G., Nordyke, R. J., Isonaka, S. & Halbert, R. J. Scoring system and clinical use of Chronic obstructive pulmonary disease diagnostic questionnaires. Chest 129, 1531–1539 (2006).

  • 10.

    Global Initiative for Bronchial asthma. (2015) Global technique for bronchial asthma management and prevention. p. 149. http://world wide web.ginasthma.org

  • 11.

    Jackson, H. & Hubbard, R. Discovering chronic obstructive lung disease using peak flow rate: mix sectional survey. Br. Mediterranean. J 327, 653–654 (2003).

  • 12.

    Perez-Padilla, R., Vollmer, W., Vazquez-Garcia, J., Enright, P., Menezes, A. & Buist, A. Can an ordinary peak expiratory flow exclude severe chronic obstructive lung disease? Int. J. Tuberc. Lung Dis 13, 387–393 (2009).

  • 13.

    Tian J., Zhou Y., Cui J., Wang D., Wang X., Hu G. et al. Peak expiratory flow like a screening tool to identify air flow obstruction inside a primary healthcare setting. Int. J. Tuberc. Lung Dis 16, 674–680 (2012).

  • 14.

    Nelson S. B., LaVange L. M., Nie Y., Walsh J. W., Enright P. L., Martinez F. J. et al. Questionnaires and pocket spirometers offer an alternative method for Chronic obstructive pulmonary disease screening within the general population. Chest 142, 358–366 (2012).

  • 15.

    Mahboub, B., Alzaabi, A., Soriano, J. B., Salameh, L., Mutairi, Ya. L. & Yusufali, Aa et al. Situation-finding of chronic obstructive lung disease with questionnaire, peak flow measurements and spirometry: a mix-sectional study. BMC Res. Notes 7, 241 (2014).

  • 16.

    Akpinar-Elci, M., Fedan, K. B. & Enright, P. L. FEV6 like a surrogate for FVC in discovering airways obstruction and restriction at work. Eur. Respir. J. 27, 374–377 (2006).

  • 17.

    Bellia, V., Sorino, C., Catalano, F., Augugliaro, G., Scichilone, N. & Pistelli, R. et al. Validation of FEV6 within the seniors: correlates of performance and repeatability. Thorax 63, 60–66 (2008).

  • 18.

    Bhatt, S. P., Kim, Y.-I., Wells, J. M., Bailey, W. C., Ramsdell, J. W. & Foreman, M. G. et al. FEV(1)/FEV(6) to identify air flow obstruction. Comparisons with computed tomography and morbidity indices. Ann. Am. Thorac. Soc. 11, 335–341 (2014).

  • 19.

    Melbye, H., Medbø, A. & Crockett, A. The FEV1/FEV6 ratio is a great replacement for the FEV1/FVC ratio within the seniors. Prim. Care. Respir. J. 15, 294–298 (2006).

  • 20.

    Rosa, F. W. & Perez-Padilla, R. Camelier a, Nascimento O a, Menezes a MB, Jardim Junior. Effectiveness from the FEV1/FEV6 ratio when compared to FEV1/FVC ratio for detecting airway obstruction in subjects aged 4 decades or higher. Braz. J. Mediterranean. Biol. Res. 40, 1615–1621 (2007).

  • 21.

    Vandevoorde, J., Verbanck, S., Schuermans, D. & Vincken, W. The function of FEV6 within the recognition of airway obstruction. Respir. Mediterranean. 99, 1465–1466 (2005).

  • 22.

    Vandevoorde, J., Verbanck, S., Schuermans, D., Kartounian, J. & Vincken, W. FEV1/FEV6 and FEV6 as a substitute for FEV1/FVC and FVC within the spirometric recognition of airway obstruction and restriction. Chest 127, 1560–1564 (2005).

  • 23.

    Vandevoorde, J., Verbanck, S., Schuermans, D., Kartounian, J. & Vincken, W. Obstructive and restrictive spirometric patterns: fixed cut-offs for FEV1/FEV6 and FEV6. Eur. Respir. J. 27, 378–383 (2006).

  • 24.

    Thorn, J., Tilling, B., Lisspers, K., Jörgensen, L., Stenling, A. & Stratelis, G. et al. Improved conjecture of Chronic obstructive pulmonary disease in at-risk patients using breathing pre-screening in primary care : a genuine-existence study and price-effectiveness analysis. Prim. Care. Respir. J. 21, 159–166 (2012).

  • 25.

    van living room Bemt, L., Wouters, B. C. W., Grootens, J., Denis, J., Poels, P. J. & Schermer, T. R. Diagnostic precision of pre-bronchodilator FEV1/FEV6 from microspirometry to identify air flow obstruction in primary care: a randomised mix-sectional study. NPJ. Prim. Care. Respir. Mediterranean. 24, 14033 (2014).

  • 26.

    Frith, P., Crockett, A., Beilby, J., Marshall, D., Attewell, R. & Ratnanesan, A. et al. Simplified Chronic obstructive pulmonary disease screening: validation from the PiKo-6® in primary care. Prim. Care. Respir. J. 20, 190–198 (2011).

  • 27.

    Jithoo, A., Enright, P., Burney, P., Buist, aS., Bateman, E. D. & Tan, W. C. et al. Situation-finding choices for COPD : is a result of the BOLD Study. Eur. Respir. J 41, 548–555 (2013).

  • 28.

    Gochicoa-Rangel, L., Larios-Castañeda, P. J., Miguel-Reyes, J. L., Briseño, D. M., Flores-Campos, R. & Sáenz-López, J. A. et al. PIKO-6 versus. forced spirometry in asthmatic children. Pediatr. Pulmonol. 49, 1170–1176 (2014).

  • 29.

    Kishi, H., Shibata, Y., Osaka, D., Abe, S., Inoue, S. & Tokairin, Y. et al. FEV6 and FEV1/FEV6 in Japanese Participants from the Community-Based Annual Health Check: The Takahata Study. Intern. Mediterranean. 50, 87–93 (2011).

  • 30.

    Gleeson, S., Mitchell, B., Pasquarella, C., Reardon, E., Falsone, J. & Berman, L. Comparison of FEV6 and FVC for recognition of airway obstruction inside a community hospital lung function laboratory. Respir. Mediterranean. 100, 1397–1401 (2006).

  • 31.

    Aghili, R., Kia, M., Meysamie, A., Aghili, S. M. & Paknejad, O. Fixed Cut-Off for FEV1/FEV6 and FEV6 in Recognition of Obstructive and Restrictive Patterns. Iran Red Crescent Mediterranean. J. 15, 152–156 (2013).

  • 32.

    Kodgule, R. R., Singh, V., Dhar, R., Saicharan, B. G., Madas, S. J. & Gogtay, Ja et al. Reference values for optimum expiratory flow in Indian adult population utilizing a Eu scale peak flow meter. J. Postgrad. Mediterranean. 60, 123–129 (2014).

  • 33.

    Miller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R. & Coates, a et al. Standardisation of spirometry. Eur. Respir. J. 26, 319–338 (2005).

  • 34.

    Crapo, R., Casaburi, R., Coates, A., Enright, P., Hankinson, J. & Irvin, C. et al. American Thoracic Society Guidelines for Methacholine and workout Challenge Testing—1999. Am. J. Respir. Crit. Care Mediterranean. 161, 309–329 (1999).

  • 35.

    Global Initiative for Chronic Obstructive Lung Disease (GOLD) (2014). In the global technique for diagnosing, management and protection against Chronic obstructive pulmonary disease. http://world wide web.goldcopd.org/

  • 36.

    Pellegrino, R. Interpretative techniques for breathing tests. Eur. Respir. J. 26, 948–968 (2005).

  • 37.

    Hajian-Tilaki, K. Sample size estimation in diagnostic test studies of biomedical informatics. J. Biomed. Inform. 48, 193–204 (2014).

  • Leave a Reply

    Your email address will not be published. Required fields are marked *